Cargando…
Research Progress and Prospect of Nanoplatforms for Treatment of Oral Cancer
Oral cancers refer to malignant tumors associated with high morbidity and mortality, and oral squamous cell carcinoma accounts for the majority of cases. It is an important part of head and neck, and oral cancer is one of the six most common cancers in the world. At present, the traditional treatmen...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7773899/ https://www.ncbi.nlm.nih.gov/pubmed/33391000 http://dx.doi.org/10.3389/fphar.2020.616101 |
_version_ | 1783630148103307264 |
---|---|
author | Zhao, Zhilong Li, Dan Wu, Ziqi Wang, Qihui Ma, Zhangyu Zhang, Congxiao |
author_facet | Zhao, Zhilong Li, Dan Wu, Ziqi Wang, Qihui Ma, Zhangyu Zhang, Congxiao |
author_sort | Zhao, Zhilong |
collection | PubMed |
description | Oral cancers refer to malignant tumors associated with high morbidity and mortality, and oral squamous cell carcinoma accounts for the majority of cases. It is an important part of head and neck, and oral cancer is one of the six most common cancers in the world. At present, the traditional treatment methods for oral cancer include surgery, radiation therapy, and chemotherapy. However, these methods have many disadvantages. In recent years, nanomedicine, the delivery of drugs through nanoplatforms for the treatment of cancer, has become a promising substitutive therapy. The use of nanoplatforms can reduce the degradation of the drug in the body and accurately deliver it to the tumor site. This minimizes the distribution of the drug to other organs, thereby reducing its toxicity and allowing higher drug concentration at the tumor site. This review introduces polymer nanoparticles, lipid-based nanoparticles, metal nanoparticles, hydrogels, exosomes, and dendrimers for the treatment of oral cancer, and discusses how these nanoplatforms play an anti-cancer effect. Finally, the review gives a slight outlook on the future prospects of nanoplatforms for oral cancer treatment. |
format | Online Article Text |
id | pubmed-7773899 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-77738992021-01-01 Research Progress and Prospect of Nanoplatforms for Treatment of Oral Cancer Zhao, Zhilong Li, Dan Wu, Ziqi Wang, Qihui Ma, Zhangyu Zhang, Congxiao Front Pharmacol Pharmacology Oral cancers refer to malignant tumors associated with high morbidity and mortality, and oral squamous cell carcinoma accounts for the majority of cases. It is an important part of head and neck, and oral cancer is one of the six most common cancers in the world. At present, the traditional treatment methods for oral cancer include surgery, radiation therapy, and chemotherapy. However, these methods have many disadvantages. In recent years, nanomedicine, the delivery of drugs through nanoplatforms for the treatment of cancer, has become a promising substitutive therapy. The use of nanoplatforms can reduce the degradation of the drug in the body and accurately deliver it to the tumor site. This minimizes the distribution of the drug to other organs, thereby reducing its toxicity and allowing higher drug concentration at the tumor site. This review introduces polymer nanoparticles, lipid-based nanoparticles, metal nanoparticles, hydrogels, exosomes, and dendrimers for the treatment of oral cancer, and discusses how these nanoplatforms play an anti-cancer effect. Finally, the review gives a slight outlook on the future prospects of nanoplatforms for oral cancer treatment. Frontiers Media S.A. 2020-12-17 /pmc/articles/PMC7773899/ /pubmed/33391000 http://dx.doi.org/10.3389/fphar.2020.616101 Text en Copyright © 2020 Zhao, Li, Wu, Wang, Ma and Zhang http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Zhao, Zhilong Li, Dan Wu, Ziqi Wang, Qihui Ma, Zhangyu Zhang, Congxiao Research Progress and Prospect of Nanoplatforms for Treatment of Oral Cancer |
title | Research Progress and Prospect of Nanoplatforms for Treatment of Oral Cancer |
title_full | Research Progress and Prospect of Nanoplatforms for Treatment of Oral Cancer |
title_fullStr | Research Progress and Prospect of Nanoplatforms for Treatment of Oral Cancer |
title_full_unstemmed | Research Progress and Prospect of Nanoplatforms for Treatment of Oral Cancer |
title_short | Research Progress and Prospect of Nanoplatforms for Treatment of Oral Cancer |
title_sort | research progress and prospect of nanoplatforms for treatment of oral cancer |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7773899/ https://www.ncbi.nlm.nih.gov/pubmed/33391000 http://dx.doi.org/10.3389/fphar.2020.616101 |
work_keys_str_mv | AT zhaozhilong researchprogressandprospectofnanoplatformsfortreatmentoforalcancer AT lidan researchprogressandprospectofnanoplatformsfortreatmentoforalcancer AT wuziqi researchprogressandprospectofnanoplatformsfortreatmentoforalcancer AT wangqihui researchprogressandprospectofnanoplatformsfortreatmentoforalcancer AT mazhangyu researchprogressandprospectofnanoplatformsfortreatmentoforalcancer AT zhangcongxiao researchprogressandprospectofnanoplatformsfortreatmentoforalcancer |